Global Gene Editing Drug Market Research Report 2026(Status and Outlook)
Gene editing drugs are an innovative biomedical treatment method that treat diseases by directly modifying a patient"s genes. These drugs use various gene editing technologies, such as CRISPR-Cas9, ZFN (zinc finger nuclease), to precisely edit the patient"s DNA sequence. Overall, the field of gene-editing drugs has great potential to treat a variety of diseases, but the field will continue to evolve and advance as ethical, safety, and legal issues are addressed.
The global Gene Editing Drug market size was estimated at USD 1636.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 14.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Gene Editing Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Gene Editing Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gene Editing Drug market.
Global Gene Editing Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
CRISPR Therapeutics
Editas Medicine
Intellia Therapeutics
Sangamo Therapeutics
Bluebird Bio
Beam Therapeutics
Yaotang Biotechnology
ICamuno Biotherapeutics
Reforgene Medicine
Star Eyed Creature
Market Segmentation (by Type)
CRISPR-Cas9 Gene Editing Drugs
Zinc Finger Nuclease Gene Editing Drugs
Others
Market Segmentation (by Application)
General Hospital
Specialty Hospital
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Gene Editing Drug Market
Overview of the regional outlook of the Gene Editing Drug Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Editing Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gene Editing Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Gene Editing Drug market size was estimated at USD 1636.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 14.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Gene Editing Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Gene Editing Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gene Editing Drug market.
Global Gene Editing Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
CRISPR Therapeutics
Editas Medicine
Intellia Therapeutics
Sangamo Therapeutics
Bluebird Bio
Beam Therapeutics
Yaotang Biotechnology
ICamuno Biotherapeutics
Reforgene Medicine
Star Eyed Creature
Market Segmentation (by Type)
CRISPR-Cas9 Gene Editing Drugs
Zinc Finger Nuclease Gene Editing Drugs
Others
Market Segmentation (by Application)
General Hospital
Specialty Hospital
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Gene Editing Drug Market
Overview of the regional outlook of the Gene Editing Drug Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Editing Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gene Editing Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Gene Editing Drug
1.2 Key Market Segments
1.2.1 Gene Editing Drug Segment by Type
1.2.2 Gene Editing Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENE EDITING DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gene Editing Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Gene Editing Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENE EDITING DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gene Editing Drug Product Life Cycle
3.3 Global Gene Editing Drug Sales by Manufacturers (2020-2025)
3.4 Global Gene Editing Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Gene Editing Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gene Editing Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Gene Editing Drug Market Competitive Situation and Trends
3.8.1 Gene Editing Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gene Editing Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GENE EDITING DRUG INDUSTRY CHAIN ANALYSIS
4.1 Gene Editing Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENE EDITING DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gene Editing Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Gene Editing Drug Market
5.7 ESG Ratings of Leading Companies
6 GENE EDITING DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Editing Drug Sales Market Share by Type (2020-2025)
6.3 Global Gene Editing Drug Market Size by Type (2020-2025)
6.4 Global Gene Editing Drug Price by Type (2020-2025)
7 GENE EDITING DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Editing Drug Market Sales by Application (2020-2025)
7.3 Global Gene Editing Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Gene Editing Drug Sales Growth Rate by Application (2020-2025)
8 GENE EDITING DRUG MARKET SALES BY REGION
8.1 Global Gene Editing Drug Sales by Region
8.1.1 Global Gene Editing Drug Sales by Region
8.1.2 Global Gene Editing Drug Sales Market Share by Region
8.2 Global Gene Editing Drug Market Size by Region
8.2.1 Global Gene Editing Drug Market Size by Region
8.2.2 Global Gene Editing Drug Market Size by Region
8.3 North America
8.3.1 North America Gene Editing Drug Sales by Country
8.3.2 North America Gene Editing Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gene Editing Drug Sales by Country
8.4.2 Europe Gene Editing Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gene Editing Drug Sales by Region
8.5.2 Asia Pacific Gene Editing Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gene Editing Drug Sales by Country
8.6.2 South America Gene Editing Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gene Editing Drug Sales by Region
8.7.2 Middle East and Africa Gene Editing Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GENE EDITING DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Gene Editing Drug by Region(2020-2025)
9.2 Global Gene Editing Drug Revenue Market Share by Region (2020-2025)
9.3 Global Gene Editing Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gene Editing Drug Production
9.4.1 North America Gene Editing Drug Production Growth Rate (2020-2025)
9.4.2 North America Gene Editing Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gene Editing Drug Production
9.5.1 Europe Gene Editing Drug Production Growth Rate (2020-2025)
9.5.2 Europe Gene Editing Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gene Editing Drug Production (2020-2025)
9.6.1 Japan Gene Editing Drug Production Growth Rate (2020-2025)
9.6.2 Japan Gene Editing Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gene Editing Drug Production (2020-2025)
9.7.1 China Gene Editing Drug Production Growth Rate (2020-2025)
9.7.2 China Gene Editing Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 CRISPR Therapeutics
10.1.1 CRISPR Therapeutics Basic Information
10.1.2 CRISPR Therapeutics Gene Editing Drug Product Overview
10.1.3 CRISPR Therapeutics Gene Editing Drug Product Market Performance
10.1.4 CRISPR Therapeutics Business Overview
10.1.5 CRISPR Therapeutics SWOT Analysis
10.1.6 CRISPR Therapeutics Recent Developments
10.2 Editas Medicine
10.2.1 Editas Medicine Basic Information
10.2.2 Editas Medicine Gene Editing Drug Product Overview
10.2.3 Editas Medicine Gene Editing Drug Product Market Performance
10.2.4 Editas Medicine Business Overview
10.2.5 Editas Medicine SWOT Analysis
10.2.6 Editas Medicine Recent Developments
10.3 Intellia Therapeutics
10.3.1 Intellia Therapeutics Basic Information
10.3.2 Intellia Therapeutics Gene Editing Drug Product Overview
10.3.3 Intellia Therapeutics Gene Editing Drug Product Market Performance
10.3.4 Intellia Therapeutics Business Overview
10.3.5 Intellia Therapeutics SWOT Analysis
10.3.6 Intellia Therapeutics Recent Developments
10.4 Sangamo Therapeutics
10.4.1 Sangamo Therapeutics Basic Information
10.4.2 Sangamo Therapeutics Gene Editing Drug Product Overview
10.4.3 Sangamo Therapeutics Gene Editing Drug Product Market Performance
10.4.4 Sangamo Therapeutics Business Overview
10.4.5 Sangamo Therapeutics Recent Developments
10.5 Bluebird Bio
10.5.1 Bluebird Bio Basic Information
10.5.2 Bluebird Bio Gene Editing Drug Product Overview
10.5.3 Bluebird Bio Gene Editing Drug Product Market Performance
10.5.4 Bluebird Bio Business Overview
10.5.5 Bluebird Bio Recent Developments
10.6 Beam Therapeutics
10.6.1 Beam Therapeutics Basic Information
10.6.2 Beam Therapeutics Gene Editing Drug Product Overview
10.6.3 Beam Therapeutics Gene Editing Drug Product Market Performance
10.6.4 Beam Therapeutics Business Overview
10.6.5 Beam Therapeutics Recent Developments
10.7 Yaotang Biotechnology
10.7.1 Yaotang Biotechnology Basic Information
10.7.2 Yaotang Biotechnology Gene Editing Drug Product Overview
10.7.3 Yaotang Biotechnology Gene Editing Drug Product Market Performance
10.7.4 Yaotang Biotechnology Business Overview
10.7.5 Yaotang Biotechnology Recent Developments
10.8 ICamuno Biotherapeutics
10.8.1 ICamuno Biotherapeutics Basic Information
10.8.2 ICamuno Biotherapeutics Gene Editing Drug Product Overview
10.8.3 ICamuno Biotherapeutics Gene Editing Drug Product Market Performance
10.8.4 ICamuno Biotherapeutics Business Overview
10.8.5 ICamuno Biotherapeutics Recent Developments
10.9 Reforgene Medicine
10.9.1 Reforgene Medicine Basic Information
10.9.2 Reforgene Medicine Gene Editing Drug Product Overview
10.9.3 Reforgene Medicine Gene Editing Drug Product Market Performance
10.9.4 Reforgene Medicine Business Overview
10.9.5 Reforgene Medicine Recent Developments
10.10 Star Eyed Creature
10.10.1 Star Eyed Creature Basic Information
10.10.2 Star Eyed Creature Gene Editing Drug Product Overview
10.10.3 Star Eyed Creature Gene Editing Drug Product Market Performance
10.10.4 Star Eyed Creature Business Overview
10.10.5 Star Eyed Creature Recent Developments
11 GENE EDITING DRUG MARKET FORECAST BY REGION
11.1 Global Gene Editing Drug Market Size Forecast
11.2 Global Gene Editing Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gene Editing Drug Market Size Forecast by Country
11.2.3 Asia Pacific Gene Editing Drug Market Size Forecast by Region
11.2.4 South America Gene Editing Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gene Editing Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Gene Editing Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Gene Editing Drug by Type (2026-2035)
12.1.2 Global Gene Editing Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Gene Editing Drug by Type (2026-2035)
12.2 Global Gene Editing Drug Market Forecast by Application (2026-2035)
12.2.1 Global Gene Editing Drug Sales (K MT) Forecast by Application
12.2.2 Global Gene Editing Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Gene Editing Drug
1.2 Key Market Segments
1.2.1 Gene Editing Drug Segment by Type
1.2.2 Gene Editing Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENE EDITING DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gene Editing Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Gene Editing Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENE EDITING DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gene Editing Drug Product Life Cycle
3.3 Global Gene Editing Drug Sales by Manufacturers (2020-2025)
3.4 Global Gene Editing Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Gene Editing Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gene Editing Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Gene Editing Drug Market Competitive Situation and Trends
3.8.1 Gene Editing Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gene Editing Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GENE EDITING DRUG INDUSTRY CHAIN ANALYSIS
4.1 Gene Editing Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENE EDITING DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gene Editing Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Gene Editing Drug Market
5.7 ESG Ratings of Leading Companies
6 GENE EDITING DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Editing Drug Sales Market Share by Type (2020-2025)
6.3 Global Gene Editing Drug Market Size by Type (2020-2025)
6.4 Global Gene Editing Drug Price by Type (2020-2025)
7 GENE EDITING DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Editing Drug Market Sales by Application (2020-2025)
7.3 Global Gene Editing Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Gene Editing Drug Sales Growth Rate by Application (2020-2025)
8 GENE EDITING DRUG MARKET SALES BY REGION
8.1 Global Gene Editing Drug Sales by Region
8.1.1 Global Gene Editing Drug Sales by Region
8.1.2 Global Gene Editing Drug Sales Market Share by Region
8.2 Global Gene Editing Drug Market Size by Region
8.2.1 Global Gene Editing Drug Market Size by Region
8.2.2 Global Gene Editing Drug Market Size by Region
8.3 North America
8.3.1 North America Gene Editing Drug Sales by Country
8.3.2 North America Gene Editing Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gene Editing Drug Sales by Country
8.4.2 Europe Gene Editing Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gene Editing Drug Sales by Region
8.5.2 Asia Pacific Gene Editing Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gene Editing Drug Sales by Country
8.6.2 South America Gene Editing Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gene Editing Drug Sales by Region
8.7.2 Middle East and Africa Gene Editing Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GENE EDITING DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Gene Editing Drug by Region(2020-2025)
9.2 Global Gene Editing Drug Revenue Market Share by Region (2020-2025)
9.3 Global Gene Editing Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gene Editing Drug Production
9.4.1 North America Gene Editing Drug Production Growth Rate (2020-2025)
9.4.2 North America Gene Editing Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gene Editing Drug Production
9.5.1 Europe Gene Editing Drug Production Growth Rate (2020-2025)
9.5.2 Europe Gene Editing Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gene Editing Drug Production (2020-2025)
9.6.1 Japan Gene Editing Drug Production Growth Rate (2020-2025)
9.6.2 Japan Gene Editing Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gene Editing Drug Production (2020-2025)
9.7.1 China Gene Editing Drug Production Growth Rate (2020-2025)
9.7.2 China Gene Editing Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 CRISPR Therapeutics
10.1.1 CRISPR Therapeutics Basic Information
10.1.2 CRISPR Therapeutics Gene Editing Drug Product Overview
10.1.3 CRISPR Therapeutics Gene Editing Drug Product Market Performance
10.1.4 CRISPR Therapeutics Business Overview
10.1.5 CRISPR Therapeutics SWOT Analysis
10.1.6 CRISPR Therapeutics Recent Developments
10.2 Editas Medicine
10.2.1 Editas Medicine Basic Information
10.2.2 Editas Medicine Gene Editing Drug Product Overview
10.2.3 Editas Medicine Gene Editing Drug Product Market Performance
10.2.4 Editas Medicine Business Overview
10.2.5 Editas Medicine SWOT Analysis
10.2.6 Editas Medicine Recent Developments
10.3 Intellia Therapeutics
10.3.1 Intellia Therapeutics Basic Information
10.3.2 Intellia Therapeutics Gene Editing Drug Product Overview
10.3.3 Intellia Therapeutics Gene Editing Drug Product Market Performance
10.3.4 Intellia Therapeutics Business Overview
10.3.5 Intellia Therapeutics SWOT Analysis
10.3.6 Intellia Therapeutics Recent Developments
10.4 Sangamo Therapeutics
10.4.1 Sangamo Therapeutics Basic Information
10.4.2 Sangamo Therapeutics Gene Editing Drug Product Overview
10.4.3 Sangamo Therapeutics Gene Editing Drug Product Market Performance
10.4.4 Sangamo Therapeutics Business Overview
10.4.5 Sangamo Therapeutics Recent Developments
10.5 Bluebird Bio
10.5.1 Bluebird Bio Basic Information
10.5.2 Bluebird Bio Gene Editing Drug Product Overview
10.5.3 Bluebird Bio Gene Editing Drug Product Market Performance
10.5.4 Bluebird Bio Business Overview
10.5.5 Bluebird Bio Recent Developments
10.6 Beam Therapeutics
10.6.1 Beam Therapeutics Basic Information
10.6.2 Beam Therapeutics Gene Editing Drug Product Overview
10.6.3 Beam Therapeutics Gene Editing Drug Product Market Performance
10.6.4 Beam Therapeutics Business Overview
10.6.5 Beam Therapeutics Recent Developments
10.7 Yaotang Biotechnology
10.7.1 Yaotang Biotechnology Basic Information
10.7.2 Yaotang Biotechnology Gene Editing Drug Product Overview
10.7.3 Yaotang Biotechnology Gene Editing Drug Product Market Performance
10.7.4 Yaotang Biotechnology Business Overview
10.7.5 Yaotang Biotechnology Recent Developments
10.8 ICamuno Biotherapeutics
10.8.1 ICamuno Biotherapeutics Basic Information
10.8.2 ICamuno Biotherapeutics Gene Editing Drug Product Overview
10.8.3 ICamuno Biotherapeutics Gene Editing Drug Product Market Performance
10.8.4 ICamuno Biotherapeutics Business Overview
10.8.5 ICamuno Biotherapeutics Recent Developments
10.9 Reforgene Medicine
10.9.1 Reforgene Medicine Basic Information
10.9.2 Reforgene Medicine Gene Editing Drug Product Overview
10.9.3 Reforgene Medicine Gene Editing Drug Product Market Performance
10.9.4 Reforgene Medicine Business Overview
10.9.5 Reforgene Medicine Recent Developments
10.10 Star Eyed Creature
10.10.1 Star Eyed Creature Basic Information
10.10.2 Star Eyed Creature Gene Editing Drug Product Overview
10.10.3 Star Eyed Creature Gene Editing Drug Product Market Performance
10.10.4 Star Eyed Creature Business Overview
10.10.5 Star Eyed Creature Recent Developments
11 GENE EDITING DRUG MARKET FORECAST BY REGION
11.1 Global Gene Editing Drug Market Size Forecast
11.2 Global Gene Editing Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gene Editing Drug Market Size Forecast by Country
11.2.3 Asia Pacific Gene Editing Drug Market Size Forecast by Region
11.2.4 South America Gene Editing Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gene Editing Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Gene Editing Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Gene Editing Drug by Type (2026-2035)
12.1.2 Global Gene Editing Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Gene Editing Drug by Type (2026-2035)
12.2 Global Gene Editing Drug Market Forecast by Application (2026-2035)
12.2.1 Global Gene Editing Drug Sales (K MT) Forecast by Application
12.2.2 Global Gene Editing Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Gene Editing Drug Market Size by Type (M USD)
Table 4. Global Gene Editing Drug Market Size by Application
Table 5. Gene Editing Drug Market Size Comparison by Region (M USD)
Table 6. Global Gene Editing Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Gene Editing Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Gene Editing Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Gene Editing Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Editing Drug as of 2025)
Table 11. Global Market Gene Editing Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Gene Editing Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gene Editing Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Gene Editing Drug Sales by Type (K MT)
Table 27. Global Gene Editing Drug Market Size by Type (M USD)
Table 28. Global Gene Editing Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Gene Editing Drug Sales Market Share by Type (2020-2025)
Table 30. Global Gene Editing Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Gene Editing Drug Market Share by Type (2020-2025)
Table 32. Global Gene Editing Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Gene Editing Drug Sales (K MT) by Application
Table 34. Global Gene Editing Drug Market Size by Application
Table 35. Global Gene Editing Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Gene Editing Drug Sales Market Share by Application (2020-2025)
Table 37. Global Gene Editing Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Gene Editing Drug Market Share by Application (2020-2025)
Table 39. Global Gene Editing Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Gene Editing Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Gene Editing Drug Sales Market Share by Region (2020-2025)
Table 42. Global Gene Editing Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Gene Editing Drug Market Size by Region (2020-2025)
Table 44. North America Gene Editing Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Gene Editing Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Gene Editing Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Gene Editing Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Gene Editing Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Gene Editing Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Gene Editing Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Gene Editing Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Gene Editing Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Gene Editing Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Gene Editing Drug Production (K MT) by Region(2020-2025)
Table 55. Global Gene Editing Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Gene Editing Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Gene Editing Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Gene Editing Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Gene Editing Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Gene Editing Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Gene Editing Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. CRISPR Therapeutics Basic Information
Table 63. CRISPR Therapeutics Gene Editing Drug Product Overview
Table 64. CRISPR Therapeutics Gene Editing Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. CRISPR Therapeutics Business Overview
Table 66. CRISPR Therapeutics SWOT Analysis
Table 67. CRISPR Therapeutics Recent Developments
Table 68. Editas Medicine Basic Information
Table 69. Editas Medicine Gene Editing Drug Product Overview
Table 70. Editas Medicine Gene Editing Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Editas Medicine Business Overview
Table 72. Editas Medicine SWOT Analysis
Table 73. Editas Medicine Recent Developments
Table 74. Intellia Therapeutics Basic Information
Table 75. Intellia Therapeutics Gene Editing Drug Product Overview
Table 76. Intellia Therapeutics Gene Editing Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Intellia Therapeutics Business Overview
Table 78. Intellia Therapeutics SWOT Analysis
Table 79. Intellia Therapeutics Recent Developments
Table 80. Sangamo Therapeutics Basic Information
Table 81. Sangamo Therapeutics Gene Editing Drug Product Overview
Table 82. Sangamo Therapeutics Gene Editing Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Sangamo Therapeutics Business Overview
Table 84. Sangamo Therapeutics Recent Developments
Table 85. Bluebird Bio Basic Information
Table 86. Bluebird Bio Gene Editing Drug Product Overview
Table 87. Bluebird Bio Gene Editing Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Bluebird Bio Business Overview
Table 89. Bluebird Bio Recent Developments
Table 90. Beam Therapeutics Basic Information
Table 91. Beam Therapeutics Gene Editing Drug Product Overview
Table 92. Beam Therapeutics Gene Editing Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Beam Therapeutics Business Overview
Table 94. Beam Therapeutics Recent Developments
Table 95. Yaotang Biotechnology Basic Information
Table 96. Yaotang Biotechnology Gene Editing Drug Product Overview
Table 97. Yaotang Biotechnology Gene Editing Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Yaotang Biotechnology Business Overview
Table 99. Yaotang Biotechnology Recent Developments
Table 100. ICamuno Biotherapeutics Basic Information
Table 101. ICamuno Biotherapeutics Gene Editing Drug Product Overview
Table 102. ICamuno Biotherapeutics Gene Editing Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. ICamuno Biotherapeutics Business Overview
Table 104. ICamuno Biotherapeutics Recent Developments
Table 105. Reforgene Medicine Basic Information
Table 106. Reforgene Medicine Gene Editing Drug Product Overview
Table 107. Reforgene Medicine Gene Editing Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Reforgene Medicine Business Overview
Table 109. Reforgene Medicine Recent Developments
Table 110. Star Eyed Creature Basic Information
Table 111. Star Eyed Creature Gene Editing Drug Product Overview
Table 112. Star Eyed Creature Gene Editing Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Star Eyed Creature Business Overview
Table 114. Star Eyed Creature Recent Developments
Table 115. Global Gene Editing Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 116. Global Gene Editing Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Gene Editing Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 118. North America Gene Editing Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Gene Editing Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 120. Europe Gene Editing Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Gene Editing Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 122. Asia Pacific Gene Editing Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Gene Editing Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 124. South America Gene Editing Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Gene Editing Drug Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Gene Editing Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Gene Editing Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 128. Global Gene Editing Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Gene Editing Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 130. Global Gene Editing Drug Sales (K MT) Forecast by Application (2026-2035)
Table 131. Global Gene Editing Drug Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Gene Editing Drug Market Size by Type (M USD)
Table 4. Global Gene Editing Drug Market Size by Application
Table 5. Gene Editing Drug Market Size Comparison by Region (M USD)
Table 6. Global Gene Editing Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Gene Editing Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Gene Editing Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Gene Editing Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Editing Drug as of 2025)
Table 11. Global Market Gene Editing Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Gene Editing Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gene Editing Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Gene Editing Drug Sales by Type (K MT)
Table 27. Global Gene Editing Drug Market Size by Type (M USD)
Table 28. Global Gene Editing Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Gene Editing Drug Sales Market Share by Type (2020-2025)
Table 30. Global Gene Editing Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Gene Editing Drug Market Share by Type (2020-2025)
Table 32. Global Gene Editing Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Gene Editing Drug Sales (K MT) by Application
Table 34. Global Gene Editing Drug Market Size by Application
Table 35. Global Gene Editing Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Gene Editing Drug Sales Market Share by Application (2020-2025)
Table 37. Global Gene Editing Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Gene Editing Drug Market Share by Application (2020-2025)
Table 39. Global Gene Editing Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Gene Editing Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Gene Editing Drug Sales Market Share by Region (2020-2025)
Table 42. Global Gene Editing Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Gene Editing Drug Market Size by Region (2020-2025)
Table 44. North America Gene Editing Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Gene Editing Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Gene Editing Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Gene Editing Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Gene Editing Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Gene Editing Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Gene Editing Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Gene Editing Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Gene Editing Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Gene Editing Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Gene Editing Drug Production (K MT) by Region(2020-2025)
Table 55. Global Gene Editing Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Gene Editing Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Gene Editing Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Gene Editing Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Gene Editing Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Gene Editing Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Gene Editing Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. CRISPR Therapeutics Basic Information
Table 63. CRISPR Therapeutics Gene Editing Drug Product Overview
Table 64. CRISPR Therapeutics Gene Editing Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. CRISPR Therapeutics Business Overview
Table 66. CRISPR Therapeutics SWOT Analysis
Table 67. CRISPR Therapeutics Recent Developments
Table 68. Editas Medicine Basic Information
Table 69. Editas Medicine Gene Editing Drug Product Overview
Table 70. Editas Medicine Gene Editing Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Editas Medicine Business Overview
Table 72. Editas Medicine SWOT Analysis
Table 73. Editas Medicine Recent Developments
Table 74. Intellia Therapeutics Basic Information
Table 75. Intellia Therapeutics Gene Editing Drug Product Overview
Table 76. Intellia Therapeutics Gene Editing Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Intellia Therapeutics Business Overview
Table 78. Intellia Therapeutics SWOT Analysis
Table 79. Intellia Therapeutics Recent Developments
Table 80. Sangamo Therapeutics Basic Information
Table 81. Sangamo Therapeutics Gene Editing Drug Product Overview
Table 82. Sangamo Therapeutics Gene Editing Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Sangamo Therapeutics Business Overview
Table 84. Sangamo Therapeutics Recent Developments
Table 85. Bluebird Bio Basic Information
Table 86. Bluebird Bio Gene Editing Drug Product Overview
Table 87. Bluebird Bio Gene Editing Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Bluebird Bio Business Overview
Table 89. Bluebird Bio Recent Developments
Table 90. Beam Therapeutics Basic Information
Table 91. Beam Therapeutics Gene Editing Drug Product Overview
Table 92. Beam Therapeutics Gene Editing Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Beam Therapeutics Business Overview
Table 94. Beam Therapeutics Recent Developments
Table 95. Yaotang Biotechnology Basic Information
Table 96. Yaotang Biotechnology Gene Editing Drug Product Overview
Table 97. Yaotang Biotechnology Gene Editing Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Yaotang Biotechnology Business Overview
Table 99. Yaotang Biotechnology Recent Developments
Table 100. ICamuno Biotherapeutics Basic Information
Table 101. ICamuno Biotherapeutics Gene Editing Drug Product Overview
Table 102. ICamuno Biotherapeutics Gene Editing Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. ICamuno Biotherapeutics Business Overview
Table 104. ICamuno Biotherapeutics Recent Developments
Table 105. Reforgene Medicine Basic Information
Table 106. Reforgene Medicine Gene Editing Drug Product Overview
Table 107. Reforgene Medicine Gene Editing Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Reforgene Medicine Business Overview
Table 109. Reforgene Medicine Recent Developments
Table 110. Star Eyed Creature Basic Information
Table 111. Star Eyed Creature Gene Editing Drug Product Overview
Table 112. Star Eyed Creature Gene Editing Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Star Eyed Creature Business Overview
Table 114. Star Eyed Creature Recent Developments
Table 115. Global Gene Editing Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 116. Global Gene Editing Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Gene Editing Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 118. North America Gene Editing Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Gene Editing Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 120. Europe Gene Editing Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Gene Editing Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 122. Asia Pacific Gene Editing Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Gene Editing Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 124. South America Gene Editing Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Gene Editing Drug Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Gene Editing Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Gene Editing Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 128. Global Gene Editing Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Gene Editing Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 130. Global Gene Editing Drug Sales (K MT) Forecast by Application (2026-2035)
Table 131. Global Gene Editing Drug Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Gene Editing Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene Editing Drug Market Size (M USD), 2025-2035
Figure 5. Global Gene Editing Drug Market Size (M USD) (2020-2035)
Figure 6. Global Gene Editing Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gene Editing Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gene Editing Drug Product Life Cycle
Figure 13. Gene Editing Drug Sales Share by Manufacturers in 2025
Figure 14. Global Gene Editing Drug Revenue Share by Manufacturers in 2025
Figure 15. Gene Editing Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Gene Editing Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gene Editing Drug Revenue in 2025
Figure 18. Industry Chain Map of Gene Editing Drug
Figure 19. Global Gene Editing Drug Market PEST Analysis
Figure 20. Global Gene Editing Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gene Editing Drug Market Share by Type
Figure 27. Sales Market Share of Gene Editing Drug by Type (2020-2025)
Figure 28. Sales Market Share of Gene Editing Drug by Type in 2025
Figure 29. Market Share of Gene Editing Drug by Type (2020-2025)
Figure 30. Market Share of Gene Editing Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gene Editing Drug Market Share by Application
Figure 33. Global Gene Editing Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Gene Editing Drug Sales Market Share by Application in 2025
Figure 35. Global Gene Editing Drug Market Share by Application (2020-2025)
Figure 36. Global Gene Editing Drug Market Share by Application in 2025
Figure 37. Global Gene Editing Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gene Editing Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Gene Editing Drug Market Size by Region (2020-2025)
Figure 40. North America Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Gene Editing Drug Sales Market Share by Country in 2024
Figure 43. North America Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gene Editing Drug Market Size by Country in 2024
Figure 45. U.S. Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gene Editing Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Gene Editing Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gene Editing Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gene Editing Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Gene Editing Drug Sales Market Share by Country in 2024
Figure 53. Europe Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gene Editing Drug Market Size by Country in 2024
Figure 55. Germany Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gene Editing Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Gene Editing Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gene Editing Drug Market Size by Region in 2024
Figure 68. China Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gene Editing Drug Sales and Growth Rate (K MT)
Figure 79. South America Gene Editing Drug Sales Market Share by Country in 2024
Figure 80. South America Gene Editing Drug Market Size and Growth Rate (M USD)
Figure 81. South America Gene Editing Drug Market Size by Country in 2024
Figure 82. Brazil Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gene Editing Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Gene Editing Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gene Editing Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gene Editing Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gene Editing Drug Production Market Share by Region (2020-2025)
Figure 103. North America Gene Editing Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Gene Editing Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Gene Editing Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Gene Editing Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Gene Editing Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Gene Editing Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Gene Editing Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Gene Editing Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Gene Editing Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Gene Editing Drug Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Gene Editing Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene Editing Drug Market Size (M USD), 2025-2035
Figure 5. Global Gene Editing Drug Market Size (M USD) (2020-2035)
Figure 6. Global Gene Editing Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gene Editing Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gene Editing Drug Product Life Cycle
Figure 13. Gene Editing Drug Sales Share by Manufacturers in 2025
Figure 14. Global Gene Editing Drug Revenue Share by Manufacturers in 2025
Figure 15. Gene Editing Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Gene Editing Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gene Editing Drug Revenue in 2025
Figure 18. Industry Chain Map of Gene Editing Drug
Figure 19. Global Gene Editing Drug Market PEST Analysis
Figure 20. Global Gene Editing Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gene Editing Drug Market Share by Type
Figure 27. Sales Market Share of Gene Editing Drug by Type (2020-2025)
Figure 28. Sales Market Share of Gene Editing Drug by Type in 2025
Figure 29. Market Share of Gene Editing Drug by Type (2020-2025)
Figure 30. Market Share of Gene Editing Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gene Editing Drug Market Share by Application
Figure 33. Global Gene Editing Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Gene Editing Drug Sales Market Share by Application in 2025
Figure 35. Global Gene Editing Drug Market Share by Application (2020-2025)
Figure 36. Global Gene Editing Drug Market Share by Application in 2025
Figure 37. Global Gene Editing Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gene Editing Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Gene Editing Drug Market Size by Region (2020-2025)
Figure 40. North America Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Gene Editing Drug Sales Market Share by Country in 2024
Figure 43. North America Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gene Editing Drug Market Size by Country in 2024
Figure 45. U.S. Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gene Editing Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Gene Editing Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gene Editing Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gene Editing Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Gene Editing Drug Sales Market Share by Country in 2024
Figure 53. Europe Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gene Editing Drug Market Size by Country in 2024
Figure 55. Germany Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gene Editing Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Gene Editing Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gene Editing Drug Market Size by Region in 2024
Figure 68. China Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gene Editing Drug Sales and Growth Rate (K MT)
Figure 79. South America Gene Editing Drug Sales Market Share by Country in 2024
Figure 80. South America Gene Editing Drug Market Size and Growth Rate (M USD)
Figure 81. South America Gene Editing Drug Market Size by Country in 2024
Figure 82. Brazil Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gene Editing Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Gene Editing Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gene Editing Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gene Editing Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gene Editing Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Gene Editing Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gene Editing Drug Production Market Share by Region (2020-2025)
Figure 103. North America Gene Editing Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Gene Editing Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Gene Editing Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Gene Editing Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Gene Editing Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Gene Editing Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Gene Editing Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Gene Editing Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Gene Editing Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Gene Editing Drug Market Share Forecast by Application (2026-2035)
